Ignite Creation Date:
2025-12-25 @ 2:31 AM
Ignite Modification Date:
2025-12-30 @ 4:21 AM
Study NCT ID:
NCT01856634
Status:
COMPLETED
Last Update Posted:
2018-01-30
First Post:
2013-05-15
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Pharmacokinetic and Safety Trial to Determine the Appropriate Dose for Pediatric Patients With Multidrug Resistant Tuberculosis
Sponsor:
Otsuka Pharmaceutical Development & Commercialization, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-06-14
Start Date Type:
ACTUAL
Primary Completion Date:
2017-12-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-12-28
Completion Date Type:
ACTUAL
First Submit Date:
2013-05-15
First Submit QC Date:
None
Study First Post Date:
2013-05-17
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-01-27
Last Update Post Date:
2018-01-30
Last Update Post Date Type:
ACTUAL